Association of immune and metabolic receptors C5ar and C5l2 with adiposity in women

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Poursharifi, Pegah ^a,b   Rezvani, Reza ^a   Gupta, Abhishek ^a   Lapointe, Marc ^a   Marceau, Picard ^a   Tchernof, André ^a   Cianflone, Katherine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C5AR1 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; GPR77 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; BODY MASS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNE SYSTEM; METABOLISM; MIDDLE AGED; OBESITY; OMENTUM; YOUNG ADULT;

ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; ANTHROPOMETRY; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; OBESITY; OMENTUM; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; YOUNG ADULT;

EID: 84893819985     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/413921     Document Type: Article

References (51)

1. Adamczak M., Wiecek A., The adipose tissue as an endocrine organ. Seminars in Nephrology 2013 33 2 13
2. Despres J.-P., Moorjani S., Lupien P. J., Tremblay A., Nadeau A., Bouchard C., Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1990 10 4 497 511 2-s2.0-0025300496 (Pubitemid 20220572)
3. Maury E., Brichard S. M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology 2010 314 1 1 16 2-s2.0-70350188297 10.1016/j.mce.2009.07.031
4. Nikolajczyk B., Jagannathan-Bogdan M., Denis G., The outliers become a stampede as immunometabolism reaches a tipping point. Immunological Reviews 2012 249 253 275
5. Schäffler A., Schölmerich J., Innate immunity and adipose tissue biology. Trends in Immunology 2010 31 6 228 235 2-s2.0-77953019823 10.1016/j.it.2010.03.001
6. Cianflone K., Xia Z., Chen L. Y., Critical review of acylation- stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta 2003 1609 2 127 143 2-s2.0-0037473998 10.1016/S0005-2736(02)00686-7 (Pubitemid 36120719)
7. Koistinen H. A., Vidal H., Karonen S.-L., Dusserre E., Vallier P., Koivisto V. A., Ebeling P., Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 6 1034 1039 2-s2.0-0035715733 (Pubitemid 34168665)
8. Kalant D., MacLaren R., Cui W., Samanta R., Monk P. N., Laporte S. A., Cianflone K., C5L2 is a functional receptor for acylation-stimulating protein. The Journal of Biological Chemistry 2005 280 25 23936 23944 2-s2.0-21244438039 10.1074/jbc.M406921200 (Pubitemid 40884882)
9. Gerard C., Gerard N. P., C5a anaphylatoxin and its seven transmembrane-segment receptor. Annual Review of Immunology 1994 12 775 808 2-s2.0-0028201342 (Pubitemid 24140431)
10. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade M. B., Brodbeck R. M., Krause J. E., Choe H.-R., Gerard N. P., Gerard C., C5L2, a nonsignaling C5A binding protein. Biochemistry 2003 42 31 9406 9415 2-s2.0-0041571471 10.1021/bi034489v (Pubitemid 36959248)
11. Basen-Engquist K., Chang M., Obesity and cancer risk: recent review and evidence. Current Oncology Reports 2011 13 1 71 76 2-s2.0-79551510805 10.1007/s11912-010-0139-7
12. Fonseca M. I., Ager R. R., Chu S.-H., Yazan O., Sanderson S. D., LaFerla F. M., Taylor S. M., Woodruff T. M., Tenner A. J., Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. Journal of Immunology 2009 183 2 1375 1383 2-s2.0-69249152289 10.4049/jimmunol.0901005
13. Rittirsch D., Flierl M. A., Ward P. A., Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008 8 10 776 787 2-s2.0-52949118458 10.1038/nri2402
14. Xun Z., Schmudde I., Laumonnier Y., Pandey M. K., Clark J. R., König P., Gerard N. P., Gerard C., Wills-Karp M., Köhl J., A critical role for C5L2 in the pathogenesis of experimental allergic asthma. Journal of Immunology 2010 185 11 6741 6752 2-s2.0-78650668602 10.4049/jimmunol.1000892
15. Zheng Y.-Y., Xie X., Ma Y.-T., Yang Y.-N., Fu Z.-Y., Li X.-M., Ma X., Chen B.-D., Liu F., Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease. PLoS ONE 2011 6 6 2-s2.0-79959263956 10.1371/journal.pone.0020984 e20984
16. Poursharifi P., Lapointe M., Petrin D., Devost D., Gauvreau D., Hebert T., Cianflone K., C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology. Cellular Signalling 2013 25 910 918
17. Bosmann M., Haggadone M., Zetoune F., Sarma J., Ward P. A., The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation. European Journal of Immunology 2013 43 1907 1913
18. Sarma J. V., Ward P. A., New developments in C5a receptor signaling. Cell Health Cytoskelet 2012 2012 73 82 10.2147/CHC.S27233
19. Woodruff T. M., Nandakumar K. S., Tedesco F., Inhibiting the C5-C5a receptor axis. Molecular Immunology 2011 48 14 1631 1642 2-s2.0-79960465027 10.1016/j.molimm.2011.04.014
20. Poursharifi P., Lapointe M., Fisette A., Lu H., Roy C., Munkonda M. N., Fairlie D. P., Cianflone K., C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue. Molecular and Cellular Endocrinology 2013 382 325 333
21. Bamberg C. E., Mackay C. R., Lee H., Zahra D., Jackson J., Lim Y. S., Whitfeld P. L., Craig S., Corsini E., Lu B., Gerard C., Gerard N. P., The C5a receptor (C5aR) C5L2 is a modulator of C5aR -mediated signal transduction. The Journal of Biological Chemistry 2010 285 10 7633 7644 2-s2.0-77951250395 10.1074/jbc.M109.092106
22. Smith J. D., Cianflone K., Martin J., Poirier P., Broderick T. L., Noël M., Plasma adipokine and hormone changes in mountaineers on ascent to 5300 meters. Wilderness and Environmental Medicine 2011 22 2 107 114 2-s2.0-79958723061 10.1016/j.wem.2011.01.003
23. Bustin S. A., Benes V., Garson J. A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M. W., Shipley G. L., Vandesompele J., Wittwer C. T., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009 55 4 611 622 2-s2.0-64149097786 10.1373/clinchem.2008.112797
24. Sturm R., Increases in morbid obesity in the USA: 2000-2005. Public Health 2007 121 7 492 496 2-s2.0-34250155983 10.1016/j.puhe.2007.01.006 (Pubitemid 46895458)
25. Nagao H., Kashine S., Nishizawa H., Okada T., Kimura T., Hirata A., Shimomura I., Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity. Cardiovascular Diabetology 2013 12 1, article 88
26. Tchernof A., Despres J., Pathophysiology of human visceral obesity: an update. Physiological Reviews 2013 93 359 404
27. Gao Y., Gauvreau D., Cui W., Lapointe M., Paglialunga S., Cianflone K., Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes. Acta Biochimica et Biophysica Sinica 2011 43 2 154 159 2-s2.0-79551523396 10.1093/abbs/gmq124
28. Wen Y., Wang H., MacLaren R., Wu J., Lu H., Cianflone K., Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. Journal of Cellular Biochemistry 2008 104 2 391 401 2-s2.0-43449136184 10.1002/jcb.21631 (Pubitemid 351671630)
29. Paglialunga S., Schrauwen P., Roy C., Moonen-Kornips E., Lu H., Hesselink M. K. C., Deshaies Y., Richard D., Cianflone K., Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. The Journal of Endocrinology 2007 194 2 293 304 2-s2.0-34547855090 10.1677/JOE-07-0205 (Pubitemid 47249668)
30. Huber-Lang M., Sarma J. V., Rittirsch D., Schreiber H., Weiss M., Flierl M., Younkin E., Schneider M., Suger-Wiedeck H., Gebhard F., McClintock S. D., Neff T., Zetoune F., Bruckner U., Guo R.-F., Monk P. N., Ward P. A., Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. The Journal of Immunology 2005 174 2 1104 1110 2-s2.0-19944428475 (Pubitemid 40094308)
31. Apostolidou E., Kambas K., Chrysanthopoulou A., Kourtzelis I., Speletas M., Ritis K., Mitroulis I., Genetic analysis of C5a receptors in neutrophils from patients with familial Mediterranean fever. Molecular Biology Reports 2012 39 5 5503 5510 2-s2.0-83655181379 10.1007/s11033-011-1353-6
32. Raby A.-C., Holst B., Davies J., Colmont C., Laumonnier Y., Coles B., Shah S., Hall J., Topley N., Kohl J., Morgan B. P., Labéta M. O., TLR activation enhances C5a -induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. European Journal of Immunology 2011 41 9 2741 2752 2-s2.0-80052139678 10.1002/eji.201041350
33. MacLaren R., Kalant D., Cianflone K., The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochemistry and Cell Biology 2007 85 1 11 21 2-s2.0-34249938090 10.1139/O06-207 (Pubitemid 46877384)
34. Tahiri Y., Karpe F., Tan G. D., Cianflone K., Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutrition and Metabolism 2007 4, article 11 2-s2.0-34249016636 10.1186/1743-7075-4-11 (Pubitemid 46797993)
35. Fisette A., Munkonda M., Oikonomopoulou K., Paglialunga S., Lambris J., Cianflone K., C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. Immunobiology 2013 218 127 133
36. Fisette A., Lapointe M., Cianflone K., Obesity-inducing diet promotes acylation stimulating protein resistance. Biochemical and Biophysical Research Communications 2013 437 403 407
37. Fisette A., Poursharifi P., Oikonomopoulou K., Munkonda M., Lapointe M., Cianflone K., Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice. Mediators of Inflammation 2013 2013 9 713284 10.1155/2013/713284
38. Tom F., Gauvreau D., Lapointe M., Lu H., Poursharifi P., Luo X., Cianflone K., Differential chemoattractant response in adipocytes and macrophages to the action of acylation stimulating protein. European Journal of Cell Biology 2013 92 61 69
39. Roy C., Gupta A., Fisette A., Lapointe M., Poursharifi P., Richard D., Cianflone K., C5a receptor deficiency alters energy utilization and fat storage. PLoS ONE 2013 8 e62531
40. Lim J., Iyer A., Suen J., Reid R., Brown L., Fairlie D., C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB Journal 2013 27 822 831
41. Monk P. N., Scola A.-M., Madala P., Fairlie D. P., Function, structure and therapeutic potential of complement C5a receptors. British Journal of Pharmacology 2007 152 4 429 448 2-s2.0-35348821843 10.1038/sj.bjp.0707332 (Pubitemid 47585036)
42. Proctor L. M., Arumugam T. V., Shiels I., Reid R. C., Fairlie D. P., Taylor S. M., Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. British Journal of Pharmacology 2004 142 4 756 764 2-s2.0-3242776043 10.1038/sj.bjp.0705819 (Pubitemid 38969670)
43. Blogowski W., Budkowska M., Salata D., Serwin K., Dolegowska B., Lokaj M., Starzyñska T., Clinical analysis of selected complement-derived molecules in human adipose tissue. Journal of Translational Medicine 2013 11, article 11
44. Croker D. E., Halai R., Fairlie D. P., Cooper M. A., C5a, but not C5a -des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunology & Cell Biology 2013 91 625 633
45. Rittirsch D., Flierl M. A., Nadeau B. A., Day D. E., Huber-Lang M., Mackay C. R., Zetoune F. S., Gerard N. P., Cianflone K., Köhl J., Gerard C., Sarma J. V., Ward P. A., Functional roles for C5a receptors in sepsis. Nature Medicine 2008 14 5 551 557 2-s2.0-43249098418 10.1038/nm1753 (Pubitemid 351655216)
46. Gauvreau D., Gupta A., Fisette A., Tom F., Cianflone K., Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice. PLoS ONE 2013 8 e60795
47. Yuan J., Gou S. J., Huang J., Hao J., Chen M., Zhao M. H., C5a and its receptors in human Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis. Arthritis Research & Therapy 2012 14 3, article R140
48. Milligan G., A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. British Journal of Pharmacology 2008 153 1 S216 S229 2-s2.0-40349085622 10.1038/sj.bjp.0707490 (Pubitemid 351340980)
49. Bost F., Aouadi M., Caron L., Binétruy B., The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005 87 1 51 56 2-s2.0-14544298335 10.1016/j.biochi.2004.10.018 (Pubitemid 40298765)
50. Carlson C. J., Koterski S., Sciotti R. J., Poccard G. B., Rondinone C. M., Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 2003 52 3 634 641 2-s2.0-0037341276 10.2337/diabetes.52.3. 634 (Pubitemid 36323568)
51. Saleh J., Christou N., Cianflone K., Regional specificity of ASP binding in human adipose tissue. American Journal of Physiology: Endocrinology and Metabolism 1999 276 5 E815 E821 2-s2.0-0032966873 (Pubitemid 29249598)